xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 4985 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATGRNECDV | 9 | null | 248 | 256 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205376 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 6551 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | CLERDLQRL | 9 | null | 226 | 234 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205377 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 18311 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | FVTWHRYHL | 9 | null | 216 | 224 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205378 | 1 | Table 1 | Positive-Low | true | 943.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 18325 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | FVWLHYYSV | 9 | null | 185 | 193 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205379 | 1 | Table 1 | Positive-High | true | 15.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 18739 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | GAQGQFPRV | 9 | null | 20 | 28 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205380 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 22754 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | GTLVALVGL | 9 | null | 478 | 486 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205382 | 417 | Table 1 | Positive-Low | true | 4545.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 29122 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ITTQHWLGL | 9 | null | 158 | 166 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205384 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 34764 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LAFLQYRRL | 9 | null | 490 | 498 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205385 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 36540 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LIGNESFAL | 9 | null | 234 | 242 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205386 | 1 | Table 1 | Positive-Intermediate | true | 385.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 37083 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLAFLQYRRL | 10 | null | 489 | 498 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205387 | 417 | Table 1 | Positive-Low | true | 1515.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 37772 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLSCLGCKI | 9 | null | 9 | 17 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205388 | 417 | Table 1 | Positive-Low | true | 3571.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 37773 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLSCLGCKIL | 10 | null | 9 | 18 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205389 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 37936 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLVVMGTLV | 9 | null | 473 | 481 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205390 | 417 | Table 1 | Positive-Low | true | 1351.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 43365 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | NCERKKPPV | 9 | null | 117 | 125 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205392 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 43393 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | NCSVYDFFV | 9 | null | 178 | 186 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205393 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 45034 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | NMVPFFPPV | 9 | null | 431 | 439 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205394 | 1 | Table 1 | Positive-High | true | 4.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 50952 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QGRGQCTEV | 9 | null | 56 | 64 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205395 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 51362 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QLGYSYAIDL | 10 | null | 450 | 459 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205396 | 417 | Table 1 | Positive-Low | true | 2632.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 51612 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QMGRNSMKL | 9 | null | 311 | 319 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205397 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 52748 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QVMSLHNLV | 9 | null | 364 | 372 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205398 | 1 | Table 1 | Positive-Low | true | 676.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 56706 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | SAANDPIFV | 9 | null | 385 | 393 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205399 | 417 | Table 1 | Positive-Low | true | 4545.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 59035 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | SLDDYNHLV | 9 | null | 288 | 296 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205400 | 1 | Table 1 | Positive-High | true | 26.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 59152 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | SLHNLVHSFL | 10 | null | 367 | 376 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205401 | 1 | Table 1 | Positive-Intermediate | true | 263.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 61606 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | STFSFRNAL | 9 | null | 343 | 351 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205402 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 62404 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | SVYDFFVWL | 9 | null | 180 | 188 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205403 | 1 | Table 1 | Positive-High | true | 36.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 64758 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | TLDSQVMSL | 9 | null | 360 | 368 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205404 | 1 | Table 1 | Positive-Intermediate | true | 161.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 64945 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | TLLVVMGTL | 9 | null | 472 | 480 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205406 | 417 | Table 1 | Positive-Low | true | 2632.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 64946 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | TLLVVMGTLV | 10 | null | 472 | 481 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205407 | 1 | Table 1 | Positive-Intermediate | true | 357.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 65117 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | TLVALVGLFV | 10 | null | 479 | 488 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205408 | 1 | Table 1 | Positive-High | true | 29.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 66789 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | TTQHWLGLL | 9 | null | 159 | 167 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205409 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 67680 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | VALVGLFVL | 9 | null | 481 | 489 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205410 | 417 | Table 1 | Positive-Low | true | 7143.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 67865 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | VCMTVDSLV | 9 | null | 28 | 36 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205411 | 417 | Table 1 | Positive-Low | true | 7143.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 69529 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | VLHSFTDAI | 9 | null | 394 | 402 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205413 | 1 | Table 1 | Positive-Intermediate | true | 417.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 69960 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | VMGTLVALV | 9 | null | 476 | 484 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205414 | 1 | Table 1 | Positive-High | true | 28.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 71570 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | VTWHRYHLL | 9 | null | 217 | 225 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205415 | 1 | Table 1 | Positive-Intermediate | true | 161.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 71761 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | VVMGTLVAL | 9 | null | 475 | 483 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205416 | 1 | Table 1 | Positive-Intermediate | true | 67.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 72720 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | WLGLLGPNG | 9 | null | 163 | 171 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205417 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 72850 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | WMKRFNPPA | 9 | null | 406 | 414 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205418 | 417 | Table 1 | Positive-Low | true | 8333.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 73369 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YAIDLPVSV | 9 | null | 455 | 463 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205419 | 1 | Table 1 | Positive-High | true | 16.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 76153 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YTPLMETHL | 9 | null | 502 | 510 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205420 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200095.xml | 200095 | 2023-08-18-07:00 | 9809996 | 1,998 | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). | Cancer research | M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami | 76304 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YVITTQHWL | 9 | null | 156 | 164 | 9606 | P40126.1 | null | Exact Epitope | Not determined | MhcBinding | 205421 | 1 | Table 1 | Positive-Intermediate | true | 104.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 2901 | NS1/E2 (686) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ALSTGLIHL | 9 | null | 684 | 692 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501721 | 67 | Table 1 | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 5 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 2901 | NS1/E2 (686) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ALSTGLIHL | 9 | null | 684 | 692 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | MhcBinding | 205422 | 417 | Table 1 | Positive | true | 312.5 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 9203 | Core (132) | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLMGYIPLV | 9 | null | 132 | 140 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501786 | 67 | Table 2 | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 4 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 9203 | Core (132) | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLMGYIPLV | 9 | null | 132 | 140 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501783 | 73 | Table 2 | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 4 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 9203 | Core (132) | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLMGYIPLV | 9 | null | 132 | 140 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501765 | 67 | Table 1 and figure 1A | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 4 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 9203 | Core (132) | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLMGYIPLV | 9 | null | 132 | 140 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501775 | 73 | Figure 1B | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 4 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 9203 | Core (132) | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLMGYIPLV | 9 | null | 132 | 140 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | MhcBinding | 205423 | 417 | Table 1 | Positive | true | 80.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 16725 | NS1/E2 (728) | FragmentOfANaturalSequenceMolecule | Peptide from protein | FLLLADARV | 9 | null | 723 | 731 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501766 | 67 | Table 1 | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 3 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 16725 | NS1/E2 (728) | FragmentOfANaturalSequenceMolecule | Peptide from protein | FLLLADARV | 9 | null | 723 | 731 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | MhcBinding | 205424 | 417 | Table 1 | Positive | true | 18.2 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 24357 | NS4 (1769) | FragmentOfANaturalSequenceMolecule | Peptide from protein | HMWNFISGI | 9 | null | 1,764 | 1,772 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501780 | 73 | Table 2 | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 8 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 24357 | NS4 (1769) | FragmentOfANaturalSequenceMolecule | Peptide from protein | HMWNFISGI | 9 | null | 1,764 | 1,772 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501767 | 67 | Table 1 and figure 1A | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 8 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 24357 | NS4 (1769) | FragmentOfANaturalSequenceMolecule | Peptide from protein | HMWNFISGI | 9 | null | 1,764 | 1,772 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501773 | 73 | Figure 1B | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 8 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 24357 | NS4 (1769) | FragmentOfANaturalSequenceMolecule | Peptide from protein | HMWNFISGI | 9 | null | 1,764 | 1,772 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | MhcBinding | 205425 | 417 | Table 1 | Positive | true | 15.2 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 26954 | NS4 (1851) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILAGYGAGV | 9 | null | 1,851 | 1,859 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501768 | 67 | Table 1 and figure 1A | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 1 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 26954 | NS4 (1851) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILAGYGAGV | 9 | null | 1,851 | 1,859 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501785 | 67 | Table 2 | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 1 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 26954 | NS4 (1851) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILAGYGAGV | 9 | null | 1,851 | 1,859 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501784 | 73 | Table 2 | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 1 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 26954 | NS4 (1851) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILAGYGAGV | 9 | null | 1,851 | 1,859 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501774 | 73 | Figure 1B | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 1 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 26954 | NS4 (1851) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILAGYGAGV | 9 | null | 1,851 | 1,859 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | MhcBinding | 205426 | 417 | Table 1 | Positive | true | 116.3 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 37286 | NS4 (1812) | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLFNILGGWV | 10 | null | 1,807 | 1,816 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501769 | 67 | Table 1 | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 8 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 37286 | NS4 (1812) | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLFNILGGWV | 10 | null | 1,807 | 1,816 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | MhcBinding | 205427 | 417 | Table 1 | Positive | true | 4.2 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 74798 | Core (35) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLLPRRGPRL | 10 | null | 35 | 44 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501770 | 67 | Table 1 | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 7 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 74798 | Core (35) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLLPRRGPRL | 10 | null | 35 | 44 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | MhcBinding | 205428 | 417 | Table 1 | Positive | true | 125.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 74961 | NS4 (1590) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | TCell | 1501771 | 67 | Table 1 | Positive | true | null | 10000582 | null | null | null | 143 | null | splenocyte | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 6 |
200096.xml | 200096 | 2025-11-06-08:00 | 9831133 | 1,998 | Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. | Human immunology | J Alexander; M F Del Guercio; J D Fikes; R W Chesnut; F V Chisari; K M Chang; E Appella; A Sette | 74961 | NS4 (1590) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 3052230 | BAB18806.1 | null | Exact Epitope | Representative selection | MhcBinding | 205429 | 417 | Table 1 | Positive | true | 20.4 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1007773 | 1 | Table 1 | Positive-High | true | 8.2 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 205448 | 1 | Table 1 | Positive-Intermediate | true | 141.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 205451 | 1 | Table 1 | Positive-High | true | 40.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 205452 | 1 | Table 1 | Positive-Intermediate | true | 258.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 205453 | 1 | Table 1 | Positive-Intermediate | true | 889.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 205455 | 1 | Table 1 | Positive-Intermediate | true | 444.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 205458 | 1 | Table 1 | Positive-High | true | 14.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1007772 | 417 | Table 1 | Negative | false | 16786.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 205446 | 1 | Table 1 | Positive-High | true | 0.89 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 205449 | 1 | Table 1 | Positive-High | true | 12.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 205450 | 1 | Table 1 | Positive-Intermediate | true | 200.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 205454 | 1 | Table 1 | Positive-High | true | 53.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 205457 | 1 | Table 1 | Positive-High | true | 0.66 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 205459 | 1 | Table 1 | Positive-High | true | 31.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 205456 | 1 | Table 1 | Positive-Intermediate | true | 392.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 38564 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRMATPLLMQALPM | 24 | null | 97 | 120 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 205447 | 1 | Table 1 | Positive-Intermediate | true | 118.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205461 | 417 | Table 1 | Positive-Low | true | 3261.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205466 | 417 | Table 1 | Positive-Low | true | 1600.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205469 | 417 | Table 1 | Negative | false | 39211.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205472 | 417 | Table 1 | Negative | false | 15667.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205463 | 417 | Table 1 | Positive-Low | true | 1462.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205465 | 1 | Table 1 | Positive-High | true | 49.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205467 | 1 | Table 1 | Positive-High | true | 74.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205468 | 1 | Table 1 | Positive-High | true | 20.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205470 | 1 | Table 1 | Positive-High | true | 4.4 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205471 | 417 | Table 1 | Negative | false | 22750.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205473 | 417 | Table 1 | Negative | false | 17576.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205474 | 1 | Table 1 | Positive-High | true | 20.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205460 | 1 | Table 1 | Positive-High | true | 23.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205462 | 417 | Table 1 | Positive-Low | true | 8036.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200097.xml | 200097 | 2023-08-18-07:00 | 9844827 | 1,998 | The optimization of helper T lymphocyte (HTL) function in vaccine development. | Immunologic research | J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Representative selection | MhcBinding | 205464 | 1 | Table 1 | Positive-High | true | 25.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200098.xml | 200098 | 2023-08-18-07:00 | 9862732 | 1,998 | HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients. | Journal of immunology (Baltimore, Md. : 1950) | S R Reynolds; E Celis; A Sette; R Oratz; R L Shapiro; D Johnston; M Fotino; J C Bystryn | 1938 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | AIIDPLIYA | 9 | null | 291 | 299 | 9606 | Q01726.2 | null | Exact Epitope | Not determined | MhcBinding | 205477 | 1 | Table 1 | Positive-Intermediate | true | 238.1 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200098.xml | 200098 | 2023-08-18-07:00 | 9862732 | 1,998 | HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients. | Journal of immunology (Baltimore, Md. : 1950) | S R Reynolds; E Celis; A Sette; R Oratz; R L Shapiro; D Johnston; M Fotino; J C Bystryn | 2683 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ALLAGLVSL | 9 | null | 490 | 498 | 9606 | P14679.3 | null | Exact Epitope | Not determined | MhcBinding | 205478 | 1 | Table 1 | Positive-Intermediate | true | 76.3 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200098.xml | 200098 | 2023-08-18-07:00 | 9862732 | 1,998 | HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients. | Journal of immunology (Baltimore, Md. : 1950) | S R Reynolds; E Celis; A Sette; R Oratz; R L Shapiro; D Johnston; M Fotino; J C Bystryn | 2684 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ALLAGLVSLL | 10 | null | 490 | 499 | 9606 | P14679.3 | null | Exact Epitope | Not determined | MhcBinding | 205479 | 1 | Table 1 | Positive-Intermediate | true | 56.4 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200098.xml | 200098 | 2023-08-18-07:00 | 9862732 | 1,998 | HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients. | Journal of immunology (Baltimore, Md. : 1950) | S R Reynolds; E Celis; A Sette; R Oratz; R L Shapiro; D Johnston; M Fotino; J C Bystryn | 2747 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ALMDKSLHV | 9 | null | 56 | 64 | 9606 | Q16655.1 | null | Exact Epitope | Not determined | MhcBinding | 205480 | 1 | Table 1 | Positive-High | true | 17.2 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.